PHAC: COVID-19 Vaccine Emerging Issues Webinar: Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)

Introduction

The Public Health Agency of Canada, Thrombosis Canada and the National Collaborating Centre for Infectious Diseases (NCCID) present a webinar to inform health care providers on the treatment and reporting of Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT).

The Public Health Agency of Canada, Thrombosis Canada and the National Collaborating Centre for Infectious Diseases (NCCID) present a webinar to inform health care providers on the treatment and reporting of Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT).

Objectives of the webinar:

  • To provide an overview of Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)
  • To inform health care providers on clinical guidance for treatment of VITT
  • To give health care providers information on how to report VITT

Resources

English session:

Wednesday, April 21, 2021

1:30-2pm EDT

Moderator: Dr. Marina Salvadori, Public Health Agency of Canada

Presenter: Dr. Menaka Pai

French Session:

Friday, April 23

1:30-2pm EDT

French Moderator: Joseline Zafack, PhD, Public Health Agency of Canada

Presenter: Dr. Marc Carrier